(1.03%) 5 180.74 points
(0.46%) 38 852 points
(1.19%) 16 349 points
(0.19%) $78.63
(-1.37%) $2.17
(-0.04%) $2 330.30
(-0.21%) $27.56
(0.77%) $972.35
(0.07%) $0.929
(0.26%) $10.85
(0.08%) $0.797
(0.03%) $91.37
Live Chart Being Loaded With Signals
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines...
Stats | |
---|---|
आज की मात्रा | 6.55M |
औसत मात्रा | 8.24M |
बाजार मूल्य | 323.09B |
EPS | $0.0300 ( 2024-04-25 ) |
अगली कमाई की तारीख | ( $1.870 ) 2024-05-28 |
Last Dividend | $0.770 ( 2023-12-14 ) |
Next Dividend | $0 ( N/A ) |
P/E | 140.19 |
ATR14 | $0.0390 (0.03%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-04 | Smart Dalton | Buy | 612 | Common Stock |
2024-05-03 | Smart Dalton | Buy | 1 530 | Common Stock |
2024-05-04 | Smart Dalton | Sell | 302 | Common Stock |
2024-05-03 | Smart Dalton | Sell | 590 | Common Stock |
2024-05-03 | Smart Dalton | Buy | 516 | Common Stock |
INSIDER POWER |
---|
25.86 |
Last 99 transactions |
Buy: 1 325 861 | Sell: 852 034 |
मात्रा सहसंबंध
Merck & Co Inc सहसंबंध
10 सबसे अधिक सकारात्मक सहसंबंध |
---|
10 सबसे अधिक नकारात्मक सहसंबंध |
---|
क्या आप जानते हैं?
कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।
कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।
Merck & Co Inc सहसंबंध - मुद्रा/वस्त्र
Merck & Co Inc वित्तीय
Annual | 2023 |
राजस्व: | $59.87B |
सकल लाभ: | $43.89B (73.31 %) |
EPS: | $0.140 |
FY | 2023 |
राजस्व: | $59.87B |
सकल लाभ: | $43.89B (73.31 %) |
EPS: | $0.140 |
FY | 2022 |
राजस्व: | $59.28B |
सकल लाभ: | $41.87B (70.63 %) |
EPS: | $5.73 |
FY | 2021 |
राजस्व: | $48.70B |
सकल लाभ: | $35.08B (72.02 %) |
EPS: | $5.16 |
Financial Reports:
No articles found.
Merck & Co Inc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.690 (N/A) |
$0.730 (N/A) |
$0.730 (N/A) |
$0.730 (N/A) |
$0.730 (N/A) |
$0.770 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.00663 | 1970-06-02 |
Last Dividend | $0.770 | 2023-12-14 |
Next Dividend | $0 | N/A |
Payout Date | 2024-01-08 | |
Next Payout Date | N/A | |
# dividends | 214 | -- |
Total Paid Out | $52.58 | -- |
Avg. Dividend % Per Year | 2.07% | -- |
Score | 5.72 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 4.58 | |
Div. Directional Score | 7.99 | -- |
Year | Amount | Yield |
---|---|---|
1970 | $0.0206 | 1.40% |
1971 | $0.0292 | 2.31% |
1972 | $0.0224 | 1.35% |
1973 | $0.0327 | 1.36% |
1974 | $0.0278 | 1.31% |
1975 | $0.0371 | 2.09% |
1976 | $0.0378 | 2.04% |
1977 | $0.0411 | 2.31% |
1978 | $0.0465 | 3.27% |
1979 | $0.0530 | 2.94% |
1980 | $0.0628 | 3.34% |
1981 | $0.0702 | 3.08% |
1982 | $0.0744 | 3.28% |
1983 | $0.0757 | 3.39% |
1984 | $0.0809 | 3.37% |
1985 | $0.0875 | 3.54% |
1986 | $0.106 | 2.90% |
1987 | $0.143 | 2.14% |
1988 | $0.208 | 2.38% |
1989 | $0.274 | 3.01% |
1990 | $0.321 | 2.57% |
1991 | $0.378 | 2.66% |
1992 | $0.458 | 1.73% |
1993 | $0.506 | 2.42% |
1994 | $0.554 | 3.29% |
1995 | $0.610 | 3.34% |
1996 | $0.706 | 2.30% |
1997 | $0.830 | 2.18% |
1998 | $0.946 | 1.84% |
1999 | $1.070 | 1.50% |
2000 | $1.202 | 1.86% |
2001 | $1.316 | 1.48% |
2002 | $1.356 | 2.38% |
2003 | $4.14 | 7.45% |
2004 | $1.432 | 3.19% |
2005 | $1.452 | 4.87% |
2006 | $1.452 | 4.65% |
2007 | $1.452 | 3.46% |
2008 | $1.452 | 2.65% |
2009 | $1.452 | 4.91% |
2010 | $1.452 | 4.11% |
2011 | $1.490 | 4.33% |
2012 | $1.613 | 4.41% |
2013 | $1.650 | 4.18% |
2014 | $1.689 | 3.58% |
2015 | $1.726 | 3.16% |
2016 | $1.765 | 3.52% |
2017 | $1.802 | 3.14% |
2018 | $1.899 | 3.54% |
2019 | $2.16 | 2.99% |
2020 | $2.37 | 2.69% |
2021 | $2.61 | 3.38% |
2022 | $2.80 | 3.64% |
2023 | $2.96 | 2.66% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
LOMA | Dividend Knight | 2023-06-30 | Quarterly | 2 | 5.23% | 8.53 |
ZTR | Dividend King | 2024-02-09 | Monthly | 37 | 8.35% | 8.50 |
PCF | Dividend King | 2023-12-18 | Monthly | 38 | 7.05% | 8.50 |
PVL | Dividend King | 2023-11-15 | Monthly | 14 | 9.37% | 8.50 |
NCV | Dividend Royal | 2024-02-09 | Monthly | 22 | 7.68% | 8.50 |
JQC | Dividend Royal | 2023-11-14 | Monthly | 22 | 6.56% | 8.50 |
MTR | Dividend Diamond | 2023-10-30 | Monthly | 39 | 10.10% | 8.50 |
SBR | Dividend Royal | 2023-11-14 | Monthly | 38 | 7.74% | 8.50 |
SCM | Dividend King | 2023-12-15 | Monthly | 13 | 7.08% | 8.50 |
PDI | Dividend Royal | 2023-11-10 | Monthly | 13 | 7.86% | 8.50 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0375 | 1.500 | 9.25 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0218 | 1.200 | 9.27 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0584 | 1.500 | -0.462 | -0.693 | [0.1 - 1] |
payoutRatioTTM | 2.42 | -1.000 | 10.00 | -10.00 | [0 - 1] |
currentRatioTTM | 1.253 | 0.800 | 8.74 | 6.99 | [1 - 3] |
quickRatioTTM | 0.728 | 0.800 | -0.421 | -0.337 | [0.8 - 2.5] |
cashRatioTTM | 0.226 | 1.500 | 9.86 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.323 | -1.500 | 4.61 | -6.92 | [0 - 0.6] |
interestCoverageTTM | 7.47 | 1.000 | 8.34 | 8.34 | [3 - 30] |
operatingCashFlowPerShareTTM | 5.83 | 2.00 | 8.06 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 4.36 | 2.00 | 7.82 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.848 | -1.500 | 6.61 | -9.91 | [0 - 2.5] |
grossProfitMarginTTM | 0.747 | 1.000 | 0.889 | 0.889 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.110 | 1.000 | 9.80 | 9.80 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.431 | 1.000 | 8.72 | 8.72 | [0.2 - 2] |
assetTurnoverTTM | 0.580 | 0.800 | 9.46 | 7.57 | [0.5 - 2] |
Total Score | 11.41 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 140.06 | 1.000 | 10.00 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0584 | 2.50 | -0.297 | -0.693 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 4.36 | 2.00 | 8.55 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 2.35 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 5.83 | 2.00 | 8.06 | 10.00 | [0 - 30] |
payoutRatioTTM | 2.42 | 1.500 | 10.00 | -10.00 | [0 - 1] |
pegRatioTTM | -1.502 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.240 | 1.000 | 6.49 | 0 | [0.1 - 0.5] |
Total Score | 4.58 |
Merck & Co Inc
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
के बारे में लाइव सिग्नल्स
इस पृष्ठ पर प्रस्तुत लाइव सिग्नल्स NA को कब खरीदना या बेचना है, इसका निर्धारण करने में मदद करते हैं। सिग्नल्स में 1-मिनट की देरी हो सकती है; सभी बाजार सिग्नल्स की तरह, त्रुटि या गलतियों की संभावना होती है।
लाइव ट्रेडिंग सिग्नल्स स्थायी नहीं हैं, और getagraph.com इन सिग्नल्स पर किए गए किसी भी कार्रवाई के लिए जिम्मेदारी नहीं रखते हैं, जैसा कि उपयोग की शर्तें में वर्णित है। सिग्नल्स एक व्यापक श्रृंखला के तकनीकी विश्लेषण संकेतकों पर आधारित हैं